Girard Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.93M | Sell |
31,747
-565
| -2% | -$72.8K | 0.37% | 57 |
|
|
2024
Q1 | $4.26M | Sell |
32,312
-1,659
| -5% | -$204K | 0.4% | 57 |
|
|
2023
Q4 | $3.7M | Sell |
33,971
-829
| -2% | -$86.1K | 0.38% | 57 |
|
|
2023
Q3 | $3.58M | Sell |
34,800
-11,064
| -24% | -$1.19M | 0.4% | 55 |
|
|
2023
Q2 | $5.29M | Buy |
45,864
+20
| +0% | +$2.27K | 0.56% | 42 |
|
|
2023
Q1 | $4.88M | Sell |
45,844
-838
| -2% | -$90.5K | 0.54% | 45 |
|
|
2022
Q4 | $5.18M | Buy |
46,682
+1,959
| +4% | +$200K | 0.59% | 45 |
|
|
2022
Q3 | $3.85M | Sell |
44,723
-1,663
| -4% | -$148K | 0.51% | 49 |
|
|
2022
Q2 | $4.23M | Sell |
46,386
-1,504
| -3% | -$133K | 0.54% | 47 |
|
|
2022
Q1 | $3.93M | Sell |
47,890
-3,899
| -8% | -$307K | 0.43% | 63 |
|
|
2021
Q4 | $3.97M | Sell |
51,789
-2,968
| -5% | -$236K | 0.43% | 75 |
|
|
2021
Q3 | $4.11M | Sell |
54,757
-6,431
| -11% | -$489K | 0.52% | 61 |
|
|
2021
Q2 | $4.76M | Sell |
61,188
-10,846
| -15% | -$807K | 0.61% | 52 |
|
|
2021
Q1 | $5.3M | Sell |
72,034
-20,637
| -22% | -$1.52M | 0.76% | 38 |
|
|
2020
Q4 | $7.23M | Buy |
92,671
+2,828
| +3% | +$216K | 1.11% | 24 |
|
|
2020
Q3 | $7.11M | Buy |
89,843
+5,402
| +6% | +$423K | 1.19% | 23 |
|
|
2020
Q2 | $6.23M | Sell |
84,441
-3,659
| -4% | -$275K | 1.12% | 24 |
|
|
2020
Q1 | $6.47M | Buy |
88,100
+8,005
| +10% | +$629K | 1.29% | 20 |
|
|
2019
Q4 | $7.66M | Sell |
80,095
-8,872
| -10% | -$729K | 1.27% | 20 |
|
|
2019
Q3 | $7.15M | Sell |
88,967
-19,289
| -18% | -$1.55M | 1.33% | 21 |
|
|
2019
Q2 | $8.66M | Buy |
108,256
+2,850
| +3% | +$218K | 1.53% | 16 |
|
|
2019
Q1 | $8.37M | Sell |
105,406
-81
| -0.1% | -$6.06K | 1.56% | 14 |
|
|
2018
Q4 | $7.69M | Sell |
105,487
-1,201
| -1% | -$84.8K | 1.62% | 14 |
|
|
2018
Q3 | $7.22M | Sell |
106,688
-12,818
| -11% | -$817K | 1.28% | 22 |
|
|
2018
Q2 | $6.92M | Buy |
119,506
+6,406
| +6% | +$361K | 1.31% | 22 |
|
|
2018
Q1 | $5.88M | Buy |
113,100
+5,042
| +5% | +$272K | 1.37% | 21 |
|
|
2017
Q4 | $5.8M | Sell |
108,058
-7,584
| -7% | -$420K | 1.11% | 27 |
|
|
2017
Q3 | $7.07M | Buy |
115,642
+5,667
| +5% | +$344K | 1.46% | 15 |
|
|
2017
Q2 | $6.72M | Buy |
109,975
+22,426
| +26% | +$1.37M | 1.46% | 13 |
|
|
2017
Q1 | $5.31M | Buy |
87,549
+9,188
| +12% | +$557K | 1.28% | 19 |
|
|
2016
Q4 | $4.4M | Buy |
78,361
+5,340
| +7% | +$313K | 1.28% | 17 |
|
|
2016
Q3 | $4.35M | Buy |
73,021
+14,623
| +25% | +$855K | 1.45% | 15 |
|
|
2016
Q2 | $3.21M | Buy |
58,398
+6,425
| +12% | +$342K | 1.22% | 20 |
|
|
2016
Q1 | $2.62M | Buy |
51,973
+5,091
| +11% | +$249K | 1.15% | 23 |
|
|
2015
Q4 | $2.36M | Buy |
46,882
+4,932
| +12% | +$249K | 1.14% | 26 |
|
|
2015
Q3 | $1.98M | Buy |
41,950
+2,256
| +6% | +$120K | 1.12% | 30 |
|
|
2015
Q2 | $2.16M | Buy |
39,694
+2,139
| +6% | +$120K | 1.21% | 27 |
|
|
2015
Q1 | $2.06M | Buy |
37,555
+1,609
| +4% | +$91.1K | 1.22% | 27 |
|
|
2014
Q4 | $1.95M | Sell |
35,946
-2,081
| -5% | -$116K | 1.22% | 27 |
|
|
2014
Q3 | $2.15M | Sell |
38,027
-1,678
| -4% | -$94.2K | 1.44% | 18 |
|
|
2014
Q2 | $2.19M | Buy |
39,705
+849
| +2% | +$46.3K | 1.51% | 17 |
|
|
2014
Q1 | $2.1M | Sell |
38,856
-1,964
| -5% | -$102K | 1.49% | 19 |
|
|
2013
Q4 | $1.95M | Buy |
+40,820
| New | +$1.87M | 1.55% | 18 |
|
Other funds holding MRK
Girard Partners's MRK Position: Q2 2024 in Review
Girard Partners reduced its Merck (MRK) stake by 1.7% in Q2 2024, selling an estimated $72.8K and leaving 31,747 shares worth $3.93M. The position accounts for 0.37% of the portfolio, ranked #57.
Girard Partners first reported a position in MRK in Q4 2013 and has held it in 43 quarters since. The position peaked at $8.66M in Q2 2019. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Girard Partners held 31,747 shares of Merck worth $3.93M as of Q2 2024.
- Girard Partners sold 565 Merck shares in Q2 2024, an estimated $72.8K.
- Merck made up 0.37% of Girard Partners's portfolio in Q2 2024, its #57 holding.
- Girard Partners first reported a position in Merck in Q4 2013 and has held it in 43 quarters since.
- Girard Partners's Merck position peaked at $8.66M in Q2 2019.
- 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.